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Abstract
Axotomy of central neurons leads to functional and structural alterations which largely revert when neural progenitor cells
(NPCs) are implanted in the lesion site. The new microenvironment created by NPCs in the host tissue might modulate in
the damaged neurons the expression of a high variety of molecules with relevant roles in the repair mechanisms, including
neurotrophic factors. In the present work, we aimed to analyze changes in neurotrophic factor expression in axotomized
neurons induced by NPC implants. For this purpose, we performed immunofluorescence followed by confocal microscopy
analysis for the detection of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3) and nerve growth factor (NGF) on brainstem sections from rats with axotomy of abducens
internuclear neurons that received NPC implants (implanted group) or vehicle injections (axotomized group) in the lesion
site. Control abducens internuclear neurons were strongly immunoreactive to VEGF and BDNF but showed a weak staining
for NT-3 and NGF. Comparisons between groups revealed that lesioned neurons from animals that received NPC implants
showed a significant increase in VEGF content with respect to animals receiving vehicle injections. However, the
immunoreactivity for BDNF, which was increased in the axotomized group as compared to control, was not modified in the
implanted group. The modifications induced by NPC implants on VEGF and BDNF content were specific for the population
of axotomized abducens internuclear neurons since the neighboring abducens motoneurons were not affected. Similar
levels of NT-3 and NGF immunolabeling were obtained in injured neurons from axotomized and implanted animals. Among
all the analyzed neurotrophic factors, only VEGF was expressed by the implanted cells in the lesion site. Our results point to
a role of NPC implants in the modulation of neurotrophic factor expression by lesioned central neurons, which might
contribute to the restorative effects of these implants.
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Introduction
Axotomy of adult CNS neurons leads to severe morphofunc-
tional alterations which include synaptic stripping and reduced
firing rate [1,2]. When neurotrophic factors are delivered to the
distal stump of lesioned nerves, these alterations are largely
prevented and neuronal function is restored [3,4,5,6], which
suggests that physiological changes induced by axotomy are, at
least in part, due to the lack of target-derived trophic support.
Neurotrophic dependence of adult neurons is also evidenced by
the axotomy-induced regulation in the expression of growth
factors and/or their receptors [7,8,9], which might compensate for
the loss of retrograde trophic support through alternative path-
ways, such as anterograde, paracrine or autocrine [10].
By using the oculomotor system as the experimental model, we
have previously described that the transection of the medial
longitudinal fascicle (MLF) induces profound alterations in the
axotomized internuclear neurons of the abducens nucleus, which
are left disconnected from their target [2,11]. The abducens
nucleus is composed of motoneurons that innervate the ipsilateral
lateral rectus muscle, and a group of premotor cells, the abducens
internuclear neurons, whose axons course through the MLF to
establish synaptic contacts with medial rectus motoneurons in the
contralateral oculomotor nucleus [12]. After their axotomy,
abducens internuclear neurons show a marked reduction in firing
rate, a significant decrease in eye position and velocity sensitivities
and a noticeable stripping of synaptic afferences [2,11]. Moreover,
when a new target (embryonic tissue) is provided, lesioned
abducens internuclear neurons are able to restore their firing
properties and synaptic afferences [13,14]. It was suggested that
neurotrophic factors released by the implanted tissue probably
mediate the re-establishment of these axotomy-induced altera-
tions, a hypothesis supported by the fact that abducens in-
ternuclear neurons express the different types of trk receptors for
neurotrophins [15].
As a further step, we have explored in our central axotomy
model the effects of neural progenitor cell (NPC) implants based
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on the reported efficacy of this cell population in promoting
functional improvement of damaged CNS neurons [16,17,18].
Thus, axotomized abducens internuclear neurons largely recover
their morphophysiological properties following the implant of
NPCs at the lesion site in the MLF, as we have shown recently in
the cat [19]. Several mechanisms have been proposed to be likely
involved in the benefitial effects of the NPC implants after CNS
injury: secretion of neurotrophic and/or angiogenic factors,
restoration of synaptic transmitter release by providing local
reinnervation, re-establishment of functional afferent and efferent
connections, or change in the brain microenvironment towards
more favourable conditions for both the lesioned neurons to
survive and the implanted progenitors to integrate [20,21]. In line
with this, recent evidence suggests that implanted NPCs establish
a ‘‘cross-talk’’ or bilateral communication with host tissue cells of
relevant importance for the neuroprotective action of the implants
[22,23].
NPCs used in our study were obtained from the subventricular
zone (SVZ) of postnatal animals. In their neurogenic niche, SVZ
cells have been described to express the angiogenic factor vascular
endothelial growth factor (VEGF) and the neurotrophic factors
brain-derived neurotrophic factor (BDNF), nerve growth factor
(NGF) and neurotrophin-3 (NT-3) [24]. More precisely, SVZ
astrocytes express all the mentioned angionenic and neurotrophic
factors whereas SVZ neural progenitors selectively express VEGF
[24]. The neurobiological interest for VEGF is sharply increasing
nowadays since in addition to its well known angiogenic activity,
VEGF also exhibits neurotrophic and neuroprotective properties
[25,26,27,28]. Moreover, a role in synaptic transmission has also
been attributed to this factor. In particular, VEGF is able to
induce a depression in excitatory synaptic transmission onto
pyramidal and granule neurons of the hippocampus and also on
hypoglossal motoneurons [29,30]. On the other hand, the
neurotrophins BDNF, NT-3 and NGF, also expressed in the
SVZ niche, have been demonstrated to induce benefitial effects in
lesioned neurons after different types of brain damage [3,5,6].
In the present work, we aimed to investigate possible
modifications of neurotrophic factor expression in central injured
neurons following NPC implants which could be involved in the
physiological recovery induced by these implants. For this
purpose, we transected the MLF in adult rats and implanted
NPCs at the lesion site. Changes induced by the lesion and/or the
implant in the expression of VEGF, BDNF, NT-3 and NGF were
analyzed in the axotomized population of abducens internuclear
neurons. In addition, we also evaluated the expression of these
neurotrophic molecules by the implanted NPCs. The findings of
this study indicate that axotomy induces changes in the expression
of neurotrophic factors by injured central neurons that can be
differentially modulated by NPC implants. We propose that the
neurotrophic regulation promoted by NPCs might contribute to
the restorative effects of NPC implants.
Materials and Methods
Experiments were performed in adult and 7 day postnatal (P7)
Wistar rats in accordance with the guidelines of the European
Union (86/609/EU) and Spanish law (R.D. 120/2005 BOE 252/
34367-91, 2005) for the use and care of laboratory animals.
Surgical procedures used in this study were approved by the ethics
committee of Universidad de Sevilla.
Neural Progenitor Cell Culture and Infection
Neural progenitors were isolated from the SVZ of postnatal rats
(P7) and were expanded in the form of neurospheres essentially as
reported [31]. Briefly, the lateral walls of the lateral ventricles were
removed and enzymatically dissociated with 1 mg/ml trypsin at
37uC for 15 min. The tissue was then centrifuged at 150 g for
5 min, rinsed in Dulbecco’s modified Eagle’s medium/F12
medium 1:1 (DF-12) and centrifuged again in the same conditions.
Then, the cells were resuspended in DF-12 containing 0.7 mg/ml
ovomucoid, and mechanically disaggregated with a fire polished
Pasteur pipette. The dissociated cells were centrifuged, resus-
pended in defined medium (DM: DF-12 containing B-27
supplement, 2 mM glutamine, 100 units/ml penicillin, 100 mg/
ml streptomycin and 0.25 mg/ml amphotericin B) supplemented
with 20 ng/ml EGF and 10 ng/ml FGF-2, and maintained in an
atmosphere of 5% CO2, at 37uC. After 1–2 days, cell aggregates
known as neurospheres were formed (Figure 1A). Cells were
subcultured 48 hours after isolation and then every 3–4 days.
Neurosphere-derived cells were immunopositive for the neural
precursor marker nestin and were able to generate glial and
neuronal cells when they were induced to differentiate after plating
on adhesive substrate (supporting information S1 and Figure S1).
Neurospheres were infected with a lentiviral vector containing
a reporter gene encoding for the green fluorescent protein (GFP)
under the control of the cytomegalovirus (CMV) promoter
(generously provided by Dr. David Macı´as, Hospital Universitario
Virgen del Rocı´o, University of Seville; lentivirus titer: 36106
IFU/ml) with a multiplicity of infection of 3. Neurosphere-derived
cells were incubated for 8 hours with virus-added DM in T25
flasks containing 250,000 cells. Virus-containing medium was then
removed and replaced with fresh DM. After 48–72 hours of virus
incubation, cells from neurospheres expressed GFP as confirmed
by direct visualization in a Zeiss LSM 7 DUO confocal
microscope (Figure 1B). The phenotype of the neurosphere-
derived cells was not affected by the infection since they
maintained the same ability to generate neurons and glial cells
in differentiating conditions (data not shown).
Transection of the Medial Longitudinal Fascicle and
Neural Progenitor Cell Implantation
Under general anesthesia (4% chloral hydrate, 1 ml/100 g,
i.p.), adult rats were placed on a stereotaxic frame and a window
trephined in the occipital bone. The right MLF was transected by
means of a 750-mm width microblade aimed with a 45u anterior
angle at the following stereotaxic coordinates: 3.5 mm caudal to
lambda and 0 mm lateral [32]. Figure 1C shows the site of
axotomy in a schematic drawing of a rat brainstem parasagittal
section. Then, lesioned rats were divided into two groups
according to the type of procedure performed after the axotomy:
the implanted group and the axotomized group. Rats of the
implanted group received an injection of GFP-expressing neuro-
sphere-derived cells (one ml of a suspension of 50,000 viable cells/
ml prepared in DF-12). Cells were injected with a Hamilton
microsyringe coupled to a glass capillary in the same coordinates
of the lesion (Figures 1C–E). Rats from the axotomized group
received only vehicle injection (one ml of DF-12) after the MLF
transection.
The unilateral transection of the right MLF disrupts the axons
of the internuclear neurons of the left abducens nucleus. As the left
MLF was not transected, right side abducens internuclear neurons
remained unlesioned and were used as control neurons throughout
this study.
Eight weeks after lesion followed by cell implant or vehicle
injection, animals were perfused transcardially under deep
anesthesia (sodium pentobarbital, 50 mg/kg, i.p.) with 100 ml of
physiological saline followed by 250 ml of 4% paraformaldehyde
in 0.1 M sodium phosphate buffer, pH 7.4. The brainstem was
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removed and cryoprotected by immersion in a solution of 30%
sucrose in sodium phosphate-buffered saline (PBS) until it sank.
Then, for cryostat sectioning, the brainstem was cut in two pieces:
the more rostral one, containing the site of lesion in the MLF, was
sectioned sagitally (Figure 1C–E) and the caudal one, containing
the abducens nucleus, was sectioned coronally (schematically
represented in Figure 1F). All the sections were 40-mm thick.
Sections were divided in parallel series to be processed for different
immunostainings.
Immunohistochemistry
After washing in PBS, coronal sections containing the abducens
nucleus were incubated with 1% sodium borohydride for 10 min
for antigen retrieval. They were rinsed again in PBS and incubated
Figure 1. Neural progenitor cell culture, axotomy and cell implant. A. Floating neurosphere obtained from neural progenitors of the
postnatal rat subventricular zone (SVZ). Scale bar: 25 mm. B. GFP-expressing cells (in green) in a SVZ-derived neurosphere. Scale bar: 25 mm. C.
Schematic drawing of a rat parasagittal brainstem section showing the location of the medial longitudinal fascicle (MLF) transection and cell implant.
Abducens internuclear neurons are represented in red and implanted neural progenitor cells in green. Axons of abducens internuclear neurons (red
lines) course through the MLF towards the contralateral oculomotor nucleus. The distal stump of disrupted axons are represented in red dashed lines.
D. Confocal microscopy image of a parasagittal brainstem section showing the implanted cells labeled with GFP (in green) at the site of axotomy.
Dashed lines indicate the approximate dorso-ventral limits of the MLF. Scale bar: 100 mm. E. Higher magnification image of implanted GFP-labeled
cells. Dorso-ventral and rostro-caudal orientation as in D. Scale bar: 50 mm. F. Schematic representation of a rat coronal section through the pons
showing the abducens nucleus location. Abducens internuclear neuron somata are represented in red. Abbreviations: ABD: abducens nucleus; C:
caudal; CB: cerebellum; D: dorsal; GFP: green fluorescent protein; MLF: medial longitudinal fascicle; OCM: oculomotor nucleus; py: pyramidal tract; R:
rostral; V: ventral; 7n: facial nerve.
doi:10.1371/journal.pone.0054519.g001
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for 1 hour in a blocking solution consisting of 5% normal donkey
serum in PBS with 0.01% Triton X-100 (PBS-T). Following the
blocking treatment, sections were incubated overnight at room
temperature with one of the following primary antibodies: rabbit
anti-VEGF (Santa Cruz Biotechnology, sc-507, 1:100), rabbit anti-
BDNF (Santa Cruz Biotechnology, sc-546, 1:400) or rabbit anti-
NT-3 (Santa Cruz Biotechnology, sc-547, 1:400), prepared in
blocking solution. After several rinses in PBS, sections were
incubated with a biotinylated secondary antibody in PBS-T
(biotinylated anti-rabbit IgG Jackson ImmunoResearch, 1:500),
washed again and finally transferred for 45 minutes to a solution
containing streptavidin-FITC (Jackson ImmunoResearch, 1:800).
Then, in order to identify abducens internuclear neurons,
subsequent immunohistochemistry for the detection of calretinin
was performed since this protein is selectively expressed within the
abducens nucleus by this population of neurons [33]. The primary
antibody was a goat anti-calretinin from Swant (1:500) and the
antibody binding was made visible by incubation with an anti-
goat-TRITC (Jackson ImmunoResearch, 1:100). In other experi-
ments, when the detection of abducens motoneurons was required,
a goat anti-choline acetyltransferase (ChAT) antibody (Millipore,
1:500) followed by anti-goat-TRITC incubation was used.
Sections were then washed for several times, mounted on glass
slides and coverslipped with a 0.1 M solution of propyl gallate
prepared in glycerol:PBS (9:1).
The immunohistochemical protocol for NGF varied slightly
since a different antigen retrieval method was needed, which
consisted of incubating the sections in 0.01 M sodium citrate
buffer, pH 6, at 74uC for 40 min. The remaining protocol was the
same as described above except that incubation with the primary
antibody (rabbit anti-NGF; Santa Cruz Biotechnology, sc- 548,
1:100) lasted for 72 hours at 4uC. Finally, calretinin immunohis-
tochemistry and mounting on slides were performed as described
above.
It is important to point out that, in order to avoid differences in
immunostaining intensity due to methodological procedures, series
of sections from implanted and axotomized groups were always
processed simultaneously for each neurotrophic factor.
To analyze neurotrophic factor expression by implanted cells,
parasagittal sections containing the lesion and implant site were
processed for single immunohistochemistry for VEGF, BDNF,
NT-3 or NGF, following the same described procedure but
a streptavidin-DyLight649 was used (Jackson ImmunoResearch,
1:800) instead of a FITC-coupled streptavidin, since implanted
cells were already labeled in green by their GFP expression.
Antibody Characterization
For positive controls, the immunohistochemistry protocol was
performed in brain sections that contained areas previously
reported as immunopositive for each of the neurotrophic factors
used in this study.
Negative controls carried out by omission of the primary
antibodies resulted in absence of staining in all cases. Additional
negative controls were performed by preadsorption of the
antibodies with their blocking peptides. Specifically, each antibody
and its corresponding immunizing peptide were mixed for 2 hours
at a 1:20 proportion before being used for the immunohistochem-
ical protocol. Sections incubated with this preadsorbed solution
showed no specific staining.
For the VEGF primary antibody, a blocking peptide was not
available by the provider. Then, as negative control, the primary
antibody incubation was replaced by incubation with normal
rabbit IgG (Jackson ImmunoResearch) at the same concentration
than the primary antibody. Again, no specific labeling was found.
Confocal Microscopy and Optical Density Quantification
Confocal microscopy images of abducens neurons were
captured in order to analyze differences between groups in the
intensity of the VEGF, BDNF, NT-3 and NGF immunostainings.
For each neurotrophic factor, all abducens neurons identified in
one out of three coronal sections from each animal were captured
with a confocal laser scanning microscope (Zeiss LSM 7 DUO) at
63X magnification and 8-bit resolution. Different focal planes
containing the cell nucleus and separated 2 mm in the z axis were
scanned by exciting the FITC and TRITC fluorophores with 488-
nm argon and DPSS 561-nm lasers, respectively, with a pinhole
aperture of 1 Airy Unit. Before scanning, gray scales were adjusted
to maximize their dynamic range. Acquisition settings were kept
constant during the image capture of neurons from the left
(lesioned) and right (unlesioned) abducens nucleus of the same
section.
Captured images were analyzed with ImageJ (NIH). In order to
determine the intensity of the immunostaining, we calculated the
mean gray value of the cell immunolabeling (i.e., the optical
density) by manually outlining the cell cytoplasm in the
corresponding scanned images. Optical density measurements
have been demonstrated to correlate significantly with the amount
of protein present in the brain tissue [34] and have been widely
used by other authors to compare protein levels between groups
[35,36,37,38]. Optical density values for VEGF, BDNF, NT-3 and
NGF immunoreactivies were determined for neurons of the
lesioned and the unlesioned (control) sides of both axotomized and
implanted animals and data were finally expressed as percentages
relative to the control side.
Statistics
Comparisons between groups were carried out in Sigma Plot 11
(Systat Software) by using one-way ANOVA followed by post-hoc




Positive and negative controls were carried out to test the
specificity of the antibodies used in this study for the immunoi-
dentification of the neurotrophic factors BDNF, NT-3, NGF and
VEGF.
Initially, the immunohistochemistry protocol and the antibody
titration were established in sections containing brain regions in
which the expression of each factor has been previously described
in the literature [30,39,40,41,42,43]. Thus, immunoreactivity for
BDNF was found in rat hippocampus and the immunostaining
was not evident when the antibody was preadsorbed with its
immunizing peptide (Figures 2A and 2A’). Positive results were
obtained for NT-3 immunostaining in cerebellar Purkinje cells
(Figure 2B) and in hippocampus (not shown), and specific staining
was absent when sections were incubated with the preadsorbed
antibody (Figure 2B’). NGF immunodetection required a more
intense antigen retrieval method after which its expression was
evident in cerebellum (Figure 2C) and in hippocampus (not
shown). Again, preincubation with the blocking peptide led to
negative staining (Figure 2C’).
VEGF expression was conspicuous in Purkinje cells of the
cerebellum (Figure 2D) and in many other brain regions such as
cortex or hippocampus (not shown). As the VEGF blocking
peptide was not available (see Materials and Methods), sections
were preincubated with normal rabbit IgG instead of the rabbit-
VEGF in Lesioned Neurons after NPC Implants
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made primary antibody, which also produced negative labeling in
the cerebellum (Figure 2D’) and in the other described regions.
VEGF Immunoreactivity is Increased in Lesioned
Abducens Internuclear Neurons of Implanted Animals
As previously described, calretinin constitutes a good marker of
the internuclear neurons located in the abducens nucleus [33].
Therefore, we used calretinin immunolabeling for the identifica-
tion of this cell type. In all experimental groups (i.e., control,
axotomized and implanted), the double immunofluorescence
performed against calretinin and VEGF revealed that virtually
all calretinin-positive abducens cells were also strongly immuno-
reactive for VEGF (Figure 3A). We further evaluated the intensity
of the immunolabeling by quantifying the optical density within
the neuronal soma of abducens internuclear neurons, as described
in Materials and Methods. Thus, axotomy did not affect the
intensity of VEGF immunoreaction, since injured neurons showed
similar values of VEGF optical density in comparison with control
cells (Figure 3A and 3B). Interestingly, abducens internuclear
neurons from animals that received the NPC implants showed
a significant increase in VEGF optical density, as compared with
both control and axotomized cells (Figure 3B; p,0.05, ANOVA
test; n = 60–67 neurons in each group obtained from 5 animals).
BDNF Immunoreactivity is Increased in Lesioned Neurons
of Axotomized Animals but not of Implanted Animals
All calretinin-immunopositive neurons examined in the abdu-
cens nucleus also showed a strong immunoreactivity against
BDNF, as observed in the three experimental groups (Figure 3A).
However, the intensity of BDNF immunolabeling in abducens
internuclear neurons changed eight weeks after MLF transection.
Thus, BDNF optical density raised significantly in axotomized
neurons in relation to control values (Figure 3C). In contrast,
axotomized neurons from animals provided with NPC implants
did not exhibit any change in BDNF optical density, as compared
with the control group (Figure 3C; n = 32–54 neurons analyzed in
each group from 4 animals).
Changes in VEGF and BDNF Immunoreactivity in the
Abducens Nucleus are Selective for the Injured Cell
Population
In order to test whether the effects of central axotomy and NPC
implants on VEGF and BDNF expression were restricted to the
injured neuronal population within the abducens nucleus (i.e., the
abducens internuclear neurons) we also examined VEGF and
BDNF immunoreactivity in the motoneurons of the same nucleus,
whose axons were left intact. Abducens motoneurons were
identified by their ChAT immunostaining (Figure 4A and C).
Both VEGF and BDNF were expressed by virtually all abducens
motoneurons analyzed in the three experimental groups (n = 58–
79 motoneurons per group obtained from 3 animals) (Figure 4A–
D), but their optical density values were not affected by either the
MLF transection or the cell implantation (Figure 4E and 4F).
Therefore, abducens motoneurons did not modify their VEGF or
BDNF expression in response to the transected fascicle and NPC
implants, so that the changes found in the immunoreactivity for
these two neurotrophic molecules were specific to the population
of injured abducens internuclear neurons.
Implanted Animals do not show Changes in NT-3 or NGF
Immunoreactivity with Respect to Axotomized Animals
Abducens internuclear neurons showed a weak immunostaining
against NT-3 (Figure 5A). The analysis of optical density after NT-
3 immunolabeling revealed a significant increase of this parameter
in the cell body of abducens internuclear neurons as a result of
their axotomy (Figure 5B). Abducens internuclear neurons
axotomized but provided with the NPC implants also showed
a significant increase in NT-3 optical density as compared with
control, which was similar to that exhibited by the axotomized
group (Figure 5B). The number of calretinin-immunopositive
Figure 2. Antibody characterization. Confocal microscopy images of rat coronal sections through the hippocampus (A, A’) and cerebellum (B, B’,
C, C’) showing immunoreactivity to BDNF, NT-3, and NGF in positive controls (A, B and C, respectively) and in their respective blocking peptide-
preadsorbed negative controls (A’, B’ and C’). D and D’. Confocal microscopy images of cerebellar coronal sections showing VEGF immunoreactivity in
a positive control (D) and a negative control consisting of tissue pre-incubation with normal rabbit IgG instead of VEGF antibody (D’). Scale bars:
50 mm.
doi:10.1371/journal.pone.0054519.g002
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neurons that appeared doubly labeled following the NT-3
immunofluorescence was similar in the three experimental groups
and close to 100% (n = 25–38 neurons in each group obtained
from 4 animals).
NGF immunoreactivity was mainly confined to the neuropil of
the abducens nucleus, showing faintly-stained cell bodies
(Figure 5A). Optical density quantification evidenced no signifi-
cant change between groups in the intensity of NGF immunore-
activity, so that axotomized abducens internuclear neurons with or
without the NPC implant showed values of NGF optical density
that were similar to control (Figure 5C; n = 26–54 neurons per
group obtained from 3 animals).
VEGF Expression by the Implanted Neural Progenitor
Cells
We also aimed to explore whether implanted cells in the lesion
site might constitute a retrograde source of neurotrophic factors
for the axotomized abducens internuclear neurons, due to the
close proximity between the proximal stump of sectioned axons
and the implanted NPCs. For that, we performed VEGF, BDNF,
NT-3 and NGF immunohistochemistry in brainstem parasagittal
sections containing the lesion and NPC implantation site
(Figure 1C–E). Implanted NPCs were identified by its GFP
labeling. Approximately 25% of the GFP-positive NPCs examined
appeared also labeled following VEGF immunoreactivity. Figure 6
Figure 3. VEGF and BDNF immunoreactivity in abducens interneurons. A. Confocal microscopy images of abducens internuclear neurons
(immunopositive for calretinin, in red) showing double immunoreactivity against either VEGF (in green, second row of images) or BDNF (in green,
fourth row). Examples of neurons from the different experimental conditions are shown: non lesioned neurons (CONTROL column), lesioned neurons
from the axotomized group (AXOTOMIZED column) and lesioned neurons from the implanted group (IMPLANTED column). Bar: 20 mm. B. Optical
density quantification of VEGF immunoreactivity in unlesioned neurons (CONTROL), lesioned neurons from the axotomized group (AXOTOMIZED)
and lesioned neurons from the implanted group (IMPLANTED). Values are expressed as percentages relative to control (unlesioned neurons). Bars
represent the mean6 SEM of 60–67 neurons analyzed from five different animals in each group. * and# indicate significant differences with respect
to the control and the axotomized group, respectively (ANOVA test followed by Dunn’s method for multiple pairwise comparisons, p,0.05). C. Same
as B, but for BDNF immunoreactivity. Bars represent the mean 6 SEM of 32–54 neurons analyzed from four different animals in each group. * and #
indicate significant differences with respect to the control and the axotomized group, respectively (ANOVA test followed by Dunn’s method for
multiple pairwise comparisons, p,0.05).
doi:10.1371/journal.pone.0054519.g003
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illustrates an example of a NPC implanted at the lesion site which
showed double labeling for both GFP and VEGF immunofluo-
rescence. In contrast, none of the analyzed GFP-positive cells in
the implant was found to be immunopositive for BDNF, NT-3 or
NGF. Therefore, among all neurotrophic factors examined,
VEGF was the only that could be delivered retrogradely from
implanted cells to axotomized neurons.
Discussion
In this study, we have demonstrated that VEGF and BDNF
expression in axotomized neurons can be modulated differentially
by NPCs implanted in the site of injury. In addition, NPCs derived
from the SVZ are able to express VEGF after implantation in the
damaged brain. Based on the recently-demonstrated and relevant
functions of VEGF in neuroprotection and synaptic modulation,
we propose that this neurotrophic factor could play an important
role in the benefitial effects of NPC implants on axotomized
abducens internuclear neurons.
Transection of the MLF leaves abducens internuclear neurons
disconnected from their natural target in the oculomotor nucleus.
The axotomized neurons exhibit a profound removal of inhibitory
and excitatory synapses and a reduction in eye position and
velocity sensitivities [2,11]. In a previous work, we have shown
that NPCs implanted in the cat after transection of the MLF
induce a noticeable recovery in synaptic coverage and firing
properties altered by the axotomy [19]. As described in other
lesion models, NPCs might induce changes of protein expression
in lesioned cells which could be determinant in the mechanism of
NPC-induced recovery [21,22,23]. Therefore, we questioned
whether NPC implants were able to modify neurotrophic factor
expression in axotomized abducens internuclear neurons by
means of immunohistochemical tools. First, we had to establish
reliable immunohistochemical protocols with specific antibodies
raised against VEGF, BDNF, NT-3 and NGF. Positive controls
revealed immunolabeling in brain regions previously described to
be immunopositive for the mentioned factors such as hippocam-
pus, cerebral cortex or cerebellum [30,39,40,41,42,43]. Negative
controls were performed by preadsorption of the antibody with the
blocking peptide (for BDNF, NT-3 or NGF) or with normal IgG in
substitution of the antibody (for VEGF). It is noteworthy that we
never obtained specific labeling in these cases which indicated that
antibodies used for this study were reliable and specific.
In the control situation, we observed that all analyzed abducens
internuclear neurons displayed an intense immunoreactivity for
VEGF and BDNF, whereas NT-3 and NGF revealed a faint
staining. However, this was not the case for other brainstem
neurons which showed an intense immunoreactivity for NT-3 and
NGF (data not illustrated). Therefore, the intense labeling found in
abducens internuclear neurons specifically after VEGF and BDNF
immunoreactivity suggests that these two neurotrophic factors
likely act as important molecules for the functional maintenance of
this neuronal population, probably through autocrine or paracrine
pathways, although the retrograde and/or anterograde routes can
not be discarded.
After axotomy, abducens internuclear neurons did not modify
their immunoreactivity to VEGF. However, VEGF content was
significantly increased in these neurons when NPCs were
implanted after axotomy. Two possible explanations may account
for this finding: i) VEGF might have been retrogradely transported
by the sectioned axons and accumulated in the soma, and ii)
damaged neurons might have increased their VEGF expression in
implanted animals. Since some of the implanted cells were VEGF-
immunoreactive and abducens internuclear neurons express the
receptor for VEGF, Flk-1 (unpublished data), the first possibility is
feasible. With regard to the second possibility, it is well established
that the new microenvironment created by the cross-talk between
implanted and host tissue cells can induce changes in the neuronal
expression of certain molecules [21,22,23,44]. Therefore, it is also
possible that an increase in VEGF expression was induced in
axotomized cells as a result of molecular interactions derived from
this new microenvironment. Independently from the source,
damaged neurons of implanted animals might benefit from the
VEGF increased content. Indeed, recent evidence relates in-
creased VEGF expression with neuroprotective actions. For
instance, injured neurons after insults such as ischemia or brain
seizures increase their VEGF expression and probably this might
operate as an endogenous protective mechanism that reduces
Figure 4. VEGF and BDNF immunoreactivity in abducens motoneurons. A to D. Confocal microscopy images of control abducens
motoneurons showing double immunolabeling for ChAT (A, in red) and VEGF (B, in green), or for ChAT (C, in red) and BDNF (D, in green). Scale bar:
20 mm. E and F. Optical density (O.D.) quantification of VEGF immunoreactivity (E) and BDNF immunoreactivity (F) in abducens motoneurons from
either the unlesioned side (CON), the lesioned side of the axotomized group (AX) or the lesioned side of the implanted group (IMP). Values represent
percentages with respect to control (motoneurons from the unlesioned side). Bars show the mean6 SEM of 58–79 motoneurons analyzed from three
different animals in each group. No significant differences were obtained between groups (ANOVA test followed by Dunn’s method for multiple
pairwise comparisons).
doi:10.1371/journal.pone.0054519.g004
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neuronal excitability [27,29]. Also, overexpression of VEGF is
known to delay motor neuron degeneration in animal models of
amyotrophic lateral sclerosis [28,45]. In the cat, NPC implants are
able to restore most of the axotomy-induced alterations in firing
properties and synaptic inputs of abducens internuclear neurons
[19]. We propose that VEGF could be involved in the
neuroprotective actions exerted by NPC implants in axotomized
animals although further experiments are needed in order to
elucidate this issue.
Abducens internuclear neurons of the axotomized group
exhibited a significant increase in BDNF and NT-3 content eight
weeks after MLF transection. We have previously demonstrated
that abducens internuclear neurons express the trk receptors for
BDNF and NT-3 (trkB and trkC, respectively) [15]. Therefore, by
increasing BDNF and NT-3 expression, axotomized neurons
might compensate for the lack of target-derived trophic support
via autocrine or paracrine pathways [7,8,46]. However, in the
implanted group, BDNF content of abducens internuclear neurons
was not increased after axotomy and remained in values similar to
healthy neurons. Probably, other endogenously-released molecules
in the new microenvironment generated by the NPC implant
might replace BDNF-dependent neurotrophic actions, and conse-
quently this neurotrophin might be down-regulated as compared
to the axotomy situation. This was not the case for NT-3, since this
Figure 5. NT-3 and NGF immunoreactivity in abducens interneurons. A. Confocal images of abducens interneurons (immunopositive for
calretinin, in red) showing double immunoreactivity against either NT-3 (in green, second row of images) or NGF (in green, fourth row). Examples of
neurons from the different experimental conditions are shown: non lesioned neurons (CONTROL column), lesioned neurons from the axotomized
group (AXOTOMIZED column) and lesioned neurons from the implanted group (IMPLANTED column). Scale bar: 20 mm B. Optical density
quantification of NT-3 immunoreactivity in unlesioned neurons (CONTROL), lesioned neurons from the axotomized group (AXOTOMIZED) and
lesioned neurons from the implanted group (IMPLANTED). Values are expressed as percentages with respect to control (unlesioned neurons). Bars
represent the mean 6 SEM of 25–38 neurons analyzed from four different animals in each group. *, p,0.05 compared to the control group, no
significant differences were obtained between the axotomized and the implanted groups (ANOVA test followed by Dunn’s method for multiple
pairwise comparisons, p,0.05). C. Same as B, but for NGF immunoreactivity. Bars represent the mean 6 SEM of 26–54 neurons analyzed from three
different animals in each group. Note that there were no significant differences between groups (ANOVA test followed by Dunn’s method for
multiple pairwise comparisons, p,0.05).
doi:10.1371/journal.pone.0054519.g005
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neurotrophin increased significantly in both the axotomized and
implanted groups and, therefore, neither the NPCs nor other cells
from the host tissue that interacted with the NPCs could modify
the axotomy-induced increase in NT-3 content. Since NGF
immunoreactivity in abducens internuclear neurons was low and,
in addition, was not affected by either the axotomy or the NPC
implants, it seems that this neurotrophin is much less relevant in
control as well as after lesion and implant.
A noticeably finding of the present study was that the
motoneurons of the abducens nucleus, which lie intermingled
with the internuclear neurons, did not show any change in the
intensity of their immunostaining for either VEGF or BDNF.
Since the same methodological protocol was used for both cell
types, these data clearly validate the modifications found in the
population of abducens internuclear neurons after NPC implants
and, moreover, demonstrate that changes in neurotrophic factors
were exclusive for those neurons that were axotomized by the
lesion procedure.
As stated before, implanted cells might constitute a new source
of trophic factors for axotomized cells. In fact, NPCs from the
SVZ express VEGF in the neurogenic niche [24] and also when
they are cultured in the form of neurospheres [47]. Fagerlund
et al. [18] have recently reported that NPCs derived from the SVZ
and transplanted in the lesioned hypoglossal nucleus express
VEGF and promote motor neuron survival. In line with those
findings, we pursued to investigate in our CNS lesion model
whether SVZ neurosphere-derived cells were able to express
VEGF or other neurotrophic factors eight weeks after implanta-
tion in the host lesioned tissue. Our results showed that none of the
analyzed implanted cells were immunoreactive for BDNF, NT-3
or NGF, but a moderate percentage (approximately 25%) was
immunopositive for VEGF, which indicated that implanted NPCs
could release VEGF in the proximity of the proximal stumps of
severed axons.
In summary, this study demonstrates that NPCs implanted in
the injured brain express VEGF eight weeks after implantation in
the host lesioned tissue and are able to modulate VEGF and
BDNF expression in lesioned neurons. We propose that the
increased VEGF expression promoted by NPCs in injured neurons
might be involved in the restorative effects of NPC implants.
Supporting Information
Figure S1 Characterization of neurosphere cultures. A-B.
Phase-contrast microscopy images of floating neurospheres (A)
and dissociated neurosphere cells grown as a monolayer on a poly-
lysine substrate (B). C, E, G. Fluorescence microscopy images of
neurospheres immunostained with antibodies against nestin (C,
red), bIII-tubulin (E, arrowhead, red), GFAP (E, arrow, green) and
NG-2 (G, green) and counterstained with DAPI (blue). D, F, H.
Fluorescence microscopy images of adhered cells immunostained
with antibodies against nestin (D, red), bIII-tubulin (F, arrowhead,
red), GFAP (F, arrow, green) and NG-2 (H, green) and counter-
stained with DAPI (blue). Scale bars: 50 mm in A, B and D; 25 mm
in C and F; 15 mm in E, G and H.
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